Veeva CRM Engage Webinar Makes Virtual Events Easy and Compliant for Life Sciences
Today at Veeva European Commercial & Medical Summit , one of the largest life sciences events for commercial and medical affairs professionals in Europe, Veeva Systems (NYSE:VEEV) announced the availability of Veeva CRM Engage Webinar , the first purpose-built application to manage compliant virtual events in the life sciences industry. Veeva CRM Engage Webinar helps companies easily manage online events without compliance risk. Now marketing and medical affairs teams can open up an important digital channel to increase their reach to healthcare professionals (HCPs) and meet physicians’ growing expectations for online engagement.
Nearly all physicians (96%) say they would benefit from attending events online.1 Disparate event management systems, technology limitations, and regulatory challenges make it difficult for companies to conduct virtual events, despite the growing desire among HCPs to engage digitally with life sciences companies.
Veeva CRM Engage Webinar enables the life sciences industry to more effectively and efficiently connect with HCPs through virtual events. The application is built on Veeva CRM Events Management for a single, integrated solution to manage both physical and online events, from inviting attendees to post-event follow-up.
Also, integration with Veeva Vault ensures speakers only share approved compliant content, while Veeva CRM validates attendee credentials and gives an entire organization full visibility into interactions with HCPs across multiple channels. Now companies can deliver a seamless event experience and give HCPs faster, easier access to the content they need.
“Online events are one of the most effective and efficient ways for marketing and medical affairs teams to reach more HCPs through the channels and mobile devices they prefer,” said Andy Fuchs, senior director of commercial strategy at Veeva. “With Veeva CRM Engage Webinar, the life sciences industry finally has a purpose-built application for virtual events that is simple to use and compliant.”
The Veeva CRM Engage family of products includes Veeva CRM Engage Webinar, Veeva CRM Engage Meeting to make compliant online meetings easier and more convenient, and Veeva CRM Engage for Portals to provide HCPs with self-service online access from any device.
To learn more, register for the Veeva CRM Events Management Webinar on Thursday, 14 December at 6:00 p.m. UK time.
In other news today, Veeva announced that four of the top 20 pharmaceutical companies have adopted Veeva Align across various regions to perform fast, accurate territory alignments. Veeva also announced Veeva Vault PromoMats Brand Portal , a new digital asset management capability that makes it simple for brand managers to create portals and organize and showcase content within Veeva Vault PromoMats . Read the Veeva Align news and the Vault PromoMats Brand Portal news to learn more.
Veeva European Commercial & Medical Summit is one of the industry’s largest European events dedicated to commercial and medical solutions for life sciences. This year more than 800 life sciences professionals and industry experts will participate in the two-day conference to learn, connect, and share valuable insight on industry trends and best practices.
For more on Veeva CRM Engage Webinar, visit: veeva.com/eu/EngageWebinar
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @Veeva_EU on Twitter: twitter.com/veeva_eu
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 550 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit www.veeva.com/eu .
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the company’s filing on Form 10-Q for the period ended 31 July, 2017. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov . Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
NJ-CELGENE17.2.2018 22:02 | pressemeddelelse
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers
CELLTRION-HEALTHCARE17.2.2018 09:02 | pressemeddelelse
CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study
AVANTI-COMMUNICATIONS16.2.2018 19:28 | pressemeddelelse
Avanti Communications HYLAS 4 Satellite Arrives in French Guiana
KY-GENERAL-CABLE-CORP16.2.2018 18:07 | pressemeddelelse
General Cable Corporation Stockholders Approve Acquisition By Prysmian Group
BOEHRINGER-INGELHEIM16.2.2018 10:05 | pressemeddelelse
Systemic Sclerosis World Congress: Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease
PHILIP-MORRIS-INTL16.2.2018 09:02 | pressemeddelelse
Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum